Skip to content
Government Federal, Medical Health Aged Care

Palliative Care Pharmacist Training gets green light

Pharmaceutical Society of Australia (PSA) 2 mins read

Pharmacists will enhance support for patients receiving palliative care thanks to a new Pharmaceutical Society of Australia (PSA) training program announced as one of the successful recipients of the Australian Government’s National Palliative Care Projects grants program.

The Palliative Care Pharmacist Foundation Training program will upskill pharmacists and improve their capacity to provide palliative care.

PSA also will pilot a community palliative care pharmacist service model, with specialist palliative care pharmacists who have undertaken the training.

The training will be co-designed with subject matter experts, partner organisations and consumers.

PSA National President Dr Fei Sim FPS said the training program came after PSA delivered palliative care education and multiple projects.

“PSA has undertaken a lot of projects leading up to this point, including Primary Health Network projects, such as the Palliative Care Access to Core Medicines (PCAM),” she said.

“In South Australia we’ve delivered numerous projects for palliative care pharmacists in Aboriginal Health, in Aged Care and in community palliative care services.

“These projects have enabled timely access to palliative care medicines and support for end-of-life care for people in residential care and at home.”

Dr Sim said the new training would upskill the most easily accessible health professional to support palliative care in the community.

“Pharmacists already conduct medication reviews in the home and in residential care, providing critical care for patients on multiple medicines,” she said.

“They can provide increased support to patients, carers, including in bereavement with the additional knowledge and skills provided by the training program.”

Funding for the innovative training program and pilot of a new community palliative care pharmacist service model was announced by the Federal Government today as part of $68 million palliative care grants package*.

Dr Sim said people who reported difficulty accessing appropriate palliative care due to gender, cultural, or disability reasons would benefit through pharmacist’s receiving training in delivering care to diverse patient groups.

“Upskilling local pharmacists in palliative care will increase the capacity of community palliative care teams, community pharmacists, and general practitioners to provide care to palliative care patients,” she said.

“The service model pilot will trial and inform an ongoing model of care.

“The pharmacist will increase collaboration and coordination of local palliative care services, reducing unnecessary hospital presentations.”

Training will be available to all Australian registered pharmacists and more information of when it will launch and how to enrol will be communicated in 2024.


About us:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.


Contact details:

Georgia Clarke   M: 0480 099 798  E: [email protected]

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.